Filing Details
- Accession Number:
- 0001209191-13-009442
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-15 19:32:29
- Reporting Period:
- 2013-02-14
- Filing Date:
- 2013-02-15
- Accepted Time:
- 2013-02-15 19:32:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1243399 | Jr A Woodrow Myers | Myers Ventures Llc 1 North Illinois Street 2101 Indianapolis IN 91362 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-14 | 8,250 | $18.13 | 11,141 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-14 | 8,250 | $18.50 | 19,391 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-14 | 8,250 | $17.59 | 27,641 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-14 | 8,250 | $14.37 | 35,891 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-14 | 8,250 | $25.79 | 44,141 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-14 | 41,250 | $28.40 | 2,891 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (right to buy) | Disposition | 2013-02-14 | 8,250 | $0.00 | 8,250 | $18.13 |
| Common Stock | Director Stock Options (right to buy) | Disposition | 2013-02-14 | 8,250 | $0.00 | 8,250 | $18.50 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2013-02-14 | 8,250 | $0.00 | 8,250 | $17.59 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2013-02-14 | 8,250 | $0.00 | 8,250 | $14.37 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2013-02-14 | 8,250 | $0.00 | 8,250 | $25.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-06-13 | 2017-06-13 | No | 4 | M | Direct |
| 0 | 2009-05-22 | 2018-05-22 | No | 4 | M | Direct |
| 0 | 2010-06-09 | 2019-06-09 | No | 4 | M | Direct |
| 0 | 2011-06-11 | 2020-06-11 | No | 4 | M | Direct |
| 0 | 2012-06-10 | 2021-06-10 | No | 4 | M | Direct |
Footnotes
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $28.266 to $28.62.
- The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier.
Billionaire Hedge Funds
